Standard Chemical & Pharmaceutical Co Ltd
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more
Market Cap & Net Worth: Standard Chemical & Pharmaceutical Co Ltd (1720)
Standard Chemical & Pharmaceutical Co Ltd (TW:1720) has a market capitalization of $339.72 Million (NT$11.24 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #16242 globally and #628 in its home market, demonstrating a -2.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Standard Chemical & Pharmaceutical Co Ltd's stock price NT$62.90 by its total outstanding shares 178696000 (178.70 Million).
Standard Chemical & Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Standard Chemical & Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $148.58 Million to $339.72 Million (10.16% CAGR).
Standard Chemical & Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Standard Chemical & Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Standard Chemical & Pharmaceutical Co Ltd's market cap is 0.05 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.38x
Standard Chemical & Pharmaceutical Co Ltd's market cap is 0.38 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $148.58 Million | $3.32 Billion | $347.89 Million | 0.04x | 0.43x |
| 2016 | $130.23 Million | $3.67 Billion | $340.22 Million | 0.04x | 0.38x |
| 2017 | $147.78 Million | $3.85 Billion | $363.29 Million | 0.04x | 0.41x |
| 2018 | $135.96 Million | $3.57 Billion | $374.36 Million | 0.04x | 0.36x |
| 2019 | $152.25 Million | $3.94 Billion | $376.48 Million | 0.04x | 0.40x |
| 2020 | $176.50 Million | $4.31 Billion | $524.17 Million | 0.04x | 0.34x |
| 2021 | $211.34 Million | $4.60 Billion | $706.73 Million | 0.05x | 0.30x |
| 2022 | $318.54 Million | $5.85 Billion | $1.15 Billion | 0.05x | 0.28x |
| 2023 | $355.92 Million | $6.24 Billion | $834.89 Million | 0.06x | 0.43x |
| 2024 | $334.32 Million | $6.79 Billion | $880.50 Million | 0.05x | 0.38x |
Competitor Companies of 1720 by Market Capitalization
Companies near Standard Chemical & Pharmaceutical Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Standard Chemical & Pharmaceutical Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Standard Chemical & Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Standard Chemical & Pharmaceutical Co Ltd's market cap moved from $148.58 Million to $ 339.72 Million, with a yearly change of 10.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$339.72 Million | +6.79% |
| 2025 | NT$318.11 Million | -4.85% |
| 2024 | NT$334.32 Million | -6.07% |
| 2023 | NT$355.92 Million | +11.73% |
| 2022 | NT$318.54 Million | +50.73% |
| 2021 | NT$211.34 Million | +19.74% |
| 2020 | NT$176.50 Million | +15.93% |
| 2019 | NT$152.25 Million | +11.98% |
| 2018 | NT$135.96 Million | -8.00% |
| 2017 | NT$147.78 Million | +13.48% |
| 2016 | NT$130.23 Million | -12.35% |
| 2015 | NT$148.58 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Standard Chemical & Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $339.72 Million USD |
| MoneyControl | $339.72 Million USD |
| MarketWatch | $339.72 Million USD |
| marketcap.company | $339.72 Million USD |
| Reuters | $339.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.